Program
SGC001
A development code. Also written as “SGC001 injection”.
Its studies are mostly in Anterior Wall Myocardial Infarction · Pancreatitis · ST Elevation Myocardial Infarction, led by Beijing Sungen Biomedical Technology.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Beijing Sungen Biomedical Technology | 42 open or running | phase 2since Dec 24, 2025 | Jun 24, 2025 | Apr 2027phase 2 · NCT07306182 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jun 24, 2025First studies: 2 phase 1 studies in Anterior Wall Myocardial InfarctionFirst studyNCT07091929, NCT07079618
- Dec 24, 2025Phase 2 study in ST Elevation Myocardial InfarctionPhase 2 reachedNCT07306182 · 210 planned · China
- Aug 25, 2026Phase 2 study in PancreatitisNCT07803965 · 129 planned · China
Ahead
- Apr 2027Primary completion: phase 2 study in ST Elevation Myocardial InfarctionNCT07306182
- Nov 2027Primary completion: phase 2 study in PancreatitisNCT07803965
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07803965Pancreatitis · China | 2 | Recruiting | Nov 2027 | 129 |
| NCT07306182ST Elevation Myocardial Infarction · China | 2 | Recruiting | Apr 2027 | 210 |
| NCT07091929Anterior Wall Myocardial Infarction · China | 1 | Completed | Jul 18, 2025 | 38 |
| NCT07079618Anterior Wall Myocardial Infarction · China | 1 | Completed | Jul 15, 2025 | 49 |
How it is read
Names in the registry
- “SGC001 injection”, 3 entries
- “SGC001”, 2 entries
Codes read as this program: SGC001.
Conditions, from the studies’ own filings
- Anterior Wall Myocardial Infarction, 2 studies
- Pancreatitis, 1 study
- ST Elevation Myocardial Infarction, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.